| |
| |
|
| Insider
Information: |
Humphrey Rachel |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
146,483 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$51,100 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
146,483 |
|
|
| Total
Value |
$51,100 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytomx Therapeutics, Inc. |
CTMX |
Chief Medical Officer |
2018-03-02 |
30,234 |
2016-12-28 |
0 |
Premium* |
|
|
Black Diamond Therapeutics, Inc. |
BDTX |
Chief Medical Officer |
2020-09-08 |
10,000 |
2020-09-08 |
0 |
Premium* |
|
|
Xilio Therapeutics, Inc. |
XLO |
Director |
2021-10-21 |
9,444 |
|
0 |
Premium* |
|
|
Pyxis Oncology, Inc. |
PYXS |
|
2024-03-26 |
96,805 |
2023-03-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PYXS |
Pyxis Oncology, Inc. |
|
– • – |
2024-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
38,741 |
96,805 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
Director |
– • – |
2023-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
58,064 |
58,064 |
0 |
- |
|
| XLO |
Xilio Therapeutics, Inc. |
Director |
– • – |
2021-10-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,444 |
|
- |
|
| BDTX |
Black Diamond Therapeutic... |
Chief Medical Officer |
• – – |
2020-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2018-03-02 |
4 |
AS |
$30.00 |
$484,800 |
D/D |
(16,160) |
30,234 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2018-03-02 |
4 |
OE |
$6.61 |
$106,894 |
D/D |
16,160 |
46,394 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2018-02-28 |
4 |
AS |
$30.00 |
$715,200 |
D/D |
(23,840) |
30,234 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2018-02-28 |
4 |
OE |
$6.61 |
$157,694 |
D/D |
23,840 |
54,074 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2017-12-15 |
4 |
OE |
$6.61 |
$99,994 |
D/D |
15,117 |
30,234 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2016-12-28 |
4 |
OE |
$6.61 |
$99,994 |
D/D |
15,117 |
15,117 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
